Does PACLITAXEL Cause Malignant neoplasm progression? 3,484 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,484 reports of Malignant neoplasm progression have been filed in association with PACLITAXEL (PACLITAXEL PACLITAXEL). This represents 4.5% of all adverse event reports for PACLITAXEL.
3,484
Reports of Malignant neoplasm progression with PACLITAXEL
4.5%
of all PACLITAXEL reports
916
Deaths
760
Hospitalizations
How Dangerous Is Malignant neoplasm progression From PACLITAXEL?
Of the 3,484 reports, 916 (26.3%) resulted in death, 760 (21.8%) required hospitalization, and 155 (4.4%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PACLITAXEL. However, 3,484 reports have been filed with the FAERS database.
What Other Side Effects Does PACLITAXEL Cause?
Neutropenia (4,553)
Nausea (4,521)
Dyspnoea (4,519)
Diarrhoea (4,289)
Off label use (4,075)
Anaemia (3,949)
Neuropathy peripheral (3,508)
Fatigue (3,418)
Death (3,143)
Pyrexia (3,083)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
OSIMERTINIB (2,920)
Which PACLITAXEL Alternatives Have Lower Malignant neoplasm progression Risk?
PACLITAXEL vs PACRITINIB
PACLITAXEL vs PALBOCICLIB
PACLITAXEL vs PALIPERIDONE
PACLITAXEL vs PALIVIZUMAB
PACLITAXEL vs PALONOSETRON